Data / Form D filings / TYBR Health, Inc.
TYBR Health, Inc.: Form D filings
TYBR Health, Inc., a biotechnology company in Houston, TX, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on July 22, 2026, reports $14.4 million sold of a $30 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 HOLCOMBE BLVD. SUITE X, Houston, TX, 77021
- Phone
- (832) 384-5423
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1835188
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | New notice | $30,000,000 | $14,354,342 | $15,645,658 | 12 | Jul 9, 2026 | sec.gov |
| Nov 26, 2025 | Amendment | $7,918,951 | $7,142,974 | $775,977 | 50 | Jan 17, 2025 | sec.gov |
| Jan 31, 2025 | New notice | $2,000,000 | $1,084,679 | $915,321 | 8 | Jan 17, 2025 | sec.gov |
| Dec 9, 2020 | New notice | $1,250,000 | $709,999 | $540,001 | 8 | Nov 23, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy J. Keane Jr. | Executive Officer, Director | |
| Alex Smith | Executive Officer, Director | |
| Aaron Smith | Director | |
| Jeffrey Tyber | Director | |
| Greg Banker | Director | |
| Liz Zambory | Director | |
| Toby Hamilton | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jul 20, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TYBR Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.